A federal securities complaint filed in New Jersey alleges ADMA Biologics boosted revenue via channel stuffing and hid a related-party distribution tie after a March 24, 2026 short-seller report. (Read More)
ADMA suit shakes risk mood as Polymarket still prices 80% odds of zero 2026 cuts
1 month ago
8
A federal securities complaint filed in New Jersey alleges ADMA Biologics boosted revenue via channel stuffing and hid a related-party distribution tie after a March 24, 2026 short-seller report. (Read More)
Related
English (US)